ACCESSWIRE

3300 articles with ACCESSWIRE

• Apollo Endosurgery to Present at The LD 500 Virtual Conference

  8/26/2020

  Apollo Endosurgery, Inc. today announced that it will present at the LD 500 investor conference on Wednesday, September 2 at 11:40 AM Eastern Time.

• OPTEC International Secures Expanded Exclusive North American Distribution for OPTEC “iWands” and Hydroxyl Sterilizers.

  8/26/2020

  OPTEC International Inc., (OTC:OPTI) Today announced the company has now secured the expanded exclusive distribution rights for the North America regions for the OPTEC Hydroxyl sterilizer products.

• Myomo, Inc. to Present at The LD 500 Virtual Conference

  8/26/2020

  Myomo, Inc. today announced that it will be presenting at the LD 500 investor conference on Wednesday, September 2, 2020 at 11:00 a.m. EDT.

• Perimeter Medical Imaging AI Announces Appointment of Aaron Davidson as Director

  8/26/2020

  Perimeter Medical Imaging AI, Inc., a medical technology company driven to transform cancer surgery with advanced, real-time imaging tools to address areas of high unmet medical need, is pleased to announce that Mr. Aaron Davidson has been appointed to the Board of Directors, effective immediately.

• OpSens to Present at the LD 500 Virtual Conference

  8/26/2020

  OpSens Inc. today announced it will be presenting at the LD 500 investor conference on Tuesday, September 1st at 10:20 AM Eastern Time (7:20 AM Pacific Time).

• Molecular Partners Reports Corporate Highlights and Key Financials for H1 2020

  8/26/2020

  Molecular Partners AG, a clinical-stage biotech company that is developing a new class of custom-built proteins known as DARPin® therapeutics, announced its corporate highlights and unaudited financial results for the first half-year of 2020.

• Can-Fite to Present at The LD Micro 500 Virtual Conference on September 1, 2020

  8/26/2020

  Can-Fite BioPharma Ltd. today announced that it will be presenting at the 12th annual LD 500 on Tuesday, September 1, 2020 at 9:20 AM EST / 6:20 AM PST.

• AIM ImmunoTech to Present at The LD 500 Virtual Conference on September 1st

  8/25/2020

  AIM ImmunoTech, announced that it will be presenting at The LD 500 Investor conference being held virtually on September 1-4, 2020.

• BioSig to Present at The LD 500 Virtual Conference

  8/25/2020

  BioSig Technologies, Inc. (NASDAQ:BSGM), a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that it will be presenting at the 12 th Annual LD 500 Conference on Wednesday, September 2, 2020 at 11:40 AM ET.

• Sonnet Biotherapeutics Series A Warrants

  8/25/2020

  Sonnet BioTherapeutics Holdings, Inc. announced today that, as part of the previously announced warrant exchange agreement, all 3,300,066 Series A Warrants have been exercised at a price of $3.19 per share. Gross proceeds to the Company were $10.5 Million.

• Nephros to Present at the LD 500 Virtual Conference

  8/25/2020

  Presentation on Tuesday, September 1 st at 10:20am ET by Nephros, Inc. , today announced that it will be presenting at the LD 500 virtual investor conference on Tuesday, September 1 st at 10:20am ET. Andy Astor, President and Chief Executive Officer of Nephros

• Medexus to Present at The LD 500 Virtual Conference on September 1st

  8/25/2020

  Medexus Pharmaceuticals Inc. announced that it will be presenting at the LD 500 Investor conference being held virtually on September 1-4, 2020.

• NHI to Participate in the BMO 2020 Real Assets Conference

  8/25/2020

  National Health Investors (NYSE:NHI) announced that senior management will be conducting virtual meetings with institutional investors as part of the BMO 2020 Real Assets Conference on Wednesday, September 2, 2020.

• NowRx to Present at the LD 500 Virtual Conference

  8/25/2020

  NowRx , a tech-enabled on-demand pharmacy providing same-day and same-hour prescription delivery, today announced that it will be presenting at the LD 500 Investor Conference on September 3, 2020 at 8:40 a.m. ET / 5:40 a.m. PT. Cary Breese, CEO and Co-Founder of NowRx, will be presenting to a live virtual audience. Retail pharmacy is a $400 billion industry that relies on expensive real estate to drive foot traffic and depends on outdate

• Hancock Jaffe Enrolls Initial Patients for First-in-Human CoreoGraft Study

  8/25/2020

  Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that it has enrolled the first two patients for its first-in-human CoreoGraft study.

• Avinger Closes $5.2 Million Underwritten Public Offering of Common Stock

  8/25/2020

  Avinger, Inc. announced the closing of an underwritten public offering of 11,063,830 shares of its common stock at a price of $0.47 per share, for total gross proceeds of approximately $5.2 million, before deducting underwriting discounts, commissions and other offering expenses payable by the Company.

• Virpax Enters into License Agreement to Develop High-Density Molecular Masking Spray Formulation (MMS019) for the Prevention of Respiratory Viruses

  8/24/2020

  Virpax today announced the signing of a technology license agreement with Nanomerics Ltd. ("Nanomerics") for the exclusive North America rights to use Nanomerics' High-Density Molecular Masking Spray

• OptimizeRx to Present at the LD 500 Virtual Investor Conference on Sept. 3, 2020

  8/24/2020

  OptimizeRx Corp. (NASDAQ:OPRX), a leading provider of digital health solutions for life science companies, providers and patients, has been invited to present at the LD 500 virtual institutional investor conference being held on September 1-4, 2020.

• PharmaNest Announces New Pre-Clinical and Clinical NASH Data to Be Presented at the EASL | Digital International Liver Congress 2020

  8/24/2020

  ​​​​​PharmaNest is an image analysis company focused in the development and validation of novel standards for the quantification of Fibrosis and associated histological features for drug discovery and development. Recently, PharmaNest announced the launch of its FibroNest cloud-based and multi-vendor platform for the automated quantification of Fibrosis for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)

• Nascent Biotech Inc Completes $740,000 Equity Round of Funding

  8/24/2020

  Nascent Biotech, Inc (OTCQB:NBIO) announced today that it is closing on a direct private placement with aggregate proceeds of $740,000. The proceeds allow the Company to complete the required testing for removing the partial clinical trial hold, imposed by the FDA, and will permit the company to begin the Phase I clinical trials on brain cancer.